MoneyWorks4Me

Medicamen Biotech informs about trading plan

10 Dec 2021 Evaluate

Pursuant to Regulation 7(2)(b) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 Medicamen Biotech has informed about intimation received from Growel Remedies for sale of 14,025 Equity Shares from the open market.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..